AWH Aspira Women's Health Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: AWH

Price (delayed)

$3.49

Market cap

$43.08M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.81

Enterprise value

$43.08M

Aspira Women's Health Inc. operates as a biotech company. The Company develops and discovers testing and treatments for gynecologic issues. Aspira Women's Health serves customers in the State of Texas.

Highlights
The EPS has soared by 53% YoY and by 10% from the previous quarter
The net income has grown by 44% year-on-year and by 6% since the previous quarter
The debt has declined by 26% year-on-year but it has increased by 22% since the previous quarter
The company's equity has shrunk by 134% YoY
The company's quick ratio has shrunk by 69% YoY and by 38% QoQ
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://aspirawh.com
Peers: RNR MHLD TRV

Key stats

What are the main financial stats of AWH
Market
Shares outstanding
12.34M
Market cap
$43.08M
Enterprise value
$43.08M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
3.52
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.71
Earnings
Revenue
$9.15M
EBIT
-$16.69M
EBITDA
-$16.5M
Free cash flow
-$15.92M
Per share
EPS
-$1.81
Free cash flow per share
-$1.72
Book value per share
-$0.23
Revenue per share
$0.99
TBVPS
$0.68
Balance sheet
Total assets
$6.26M
Total liabilities
$8.63M
Debt
$2.85M
Equity
-$2.37M
Working capital
$161,000
Liquidity
Debt to equity
-1.21
Current ratio
1.03
Quick ratio
0.84
Net debt/EBITDA
0
Margins
EBITDA margin
-180.2%
Gross margin
57.5%
Net margin
-182.3%
Operating margin
-205.9%
Efficiency
Return on assets
-195.5%
Return on equity
N/A
Return on invested capital
-2,159.1%
Return on capital employed
-1,460.2%
Return on sales
-182.3%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AWH stock price

How has the Aspira Women's Health stock price performed over time
Intraday
0%
1 week
9.06%
1 month
-4.38%
1 year
-95.81%
YTD
-14.46%
QTD
12.58%

Financial performance

How have Aspira Women's Health's revenue and profit performed over time
Revenue
$9.15M
Gross profit
$5.26M
Operating income
-$18.85M
Net income
-$16.69M
Gross margin
57.5%
Net margin
-182.3%
The net margin has surged by 50% year-on-year and by 5% since the previous quarter
Aspira Women's Health's operating margin has increased by 46% YoY and by 2.1% from the previous quarter
The net income has grown by 44% year-on-year and by 6% since the previous quarter
The operating income has grown by 39% year-on-year and by 2.3% since the previous quarter

Growth

What is Aspira Women's Health's growth rate over time

Valuation

What is Aspira Women's Health stock price valuation
P/E
N/A
P/B
N/A
P/S
3.52
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.71
The EPS has soared by 53% YoY and by 10% from the previous quarter
The company's equity has shrunk by 134% YoY
AWH's price to sales (P/S) is 91% less than its 5-year quarterly average of 39.7 and 23% less than its last 4 quarters average of 4.6
Aspira Women's Health's revenue has increased by 12% YoY

Efficiency

How efficient is Aspira Women's Health business performance
Aspira Women's Health's ROIC has soared by 60% YoY but it has decreased by 24% from the previous quarter
The ROA has plunged by 57% YoY and by 25% from the previous quarter
The ROS has soared by 50% YoY and by 6% from the previous quarter

Dividends

What is AWH's dividend history
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
Recent dividends

Financial health

How did Aspira Women's Health financials performed over time
Aspira Women's Health's total assets is 27% less than its total liabilities
The company's quick ratio has shrunk by 69% YoY and by 38% QoQ
The company's current ratio has shrunk by 65% YoY and by 30% QoQ
The company's equity has shrunk by 134% YoY
Aspira Women's Health's debt to equity has soared by 66% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.